HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ann Eapen Selected Research

Carboplatin (JM8)

5/2019Somatic BRCA2 Mutation-Positive Concurrent Accessory Male Breast Cancer (BC) and Non-Small Cell Lung Cancer (NSCLC): Excellent Efficacy of Palbociclib, Fulvestrant and Leuprolide in Platinum-Exposed and Endocrine-Refractory BC Associated with Cyclin D1 and FGFR1 Amplification and of Carboplatin, Paclitaxel and Radiation in NSCLC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ann Eapen Research Topics

Disease

1Breast Neoplasms (Breast Cancer)
05/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2019
1Lung Neoplasms (Lung Cancer)
05/2019
1Male Breast Neoplasms (Male Breast Cancer)
05/2019

Drug/Important Bio-Agent (IBA)

1palbociclibIBA
05/2019
1Fulvestrant (Faslodex)FDA Link
05/2019
1Anastrozole (Arimidex)FDA LinkGeneric
05/2019
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
05/2019
1PlatinumIBA
05/2019
1Estrogen ReceptorsIBA
05/2019
1Carboplatin (JM8)FDA LinkGeneric
05/2019
1Leuprolide (Lupron)FDA LinkGeneric
05/2019
1Paclitaxel (Taxol)FDA LinkGeneric
05/2019
1Cyclin-Dependent Kinases (cdk Proteins)IBA
05/2019
1Cyclin D1IBA
05/2019

Therapy/Procedure

1Drug Therapy (Chemotherapy)
05/2019